Literature DB >> 16806945

Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.

Vishnu K Tandon1, Dharmendra B Yadav, Hardesh K Maurya, Ashok K Chaturvedi, Praveen K Shukla.   

Abstract

A series of (S)-N-(3-chloro-1,4-naphthoquinon-2-yl)-alpha-amino acid ethyl esters 3 and 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones 6-23 were synthesized and evaluated for antifungal and antibacterial activities. The structure-activity relationship of these compounds was studied and the results show that the compounds 3a and 3b exhibited in vitro antifungal activity against Candida albicans, Cryptococcus neoformans, and Sporothrix schenckii whereas compounds 12 and 22 showed in vitro antibacterial activity against Klebsiella pneumoniae and Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806945     DOI: 10.1016/j.bmc.2006.04.029

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  A novel route to synthesize libraries of quinoxalines via Petasis methodology in two synthetic operations.

Authors:  Muhammad Ayaz; Justin Dietrich; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2011-09-21       Impact factor: 2.415

2.  Ultrasound-assisted reaction of 1,4-naphthoquinone with anilines through an EDA complex.

Authors:  Elisa Leyva; Agobardo Cárdenas-Chaparro; Silvia E Loredo-Carrillo; Lluvia I López; Fernanda Méndez-Sánchez; Antonio Martínez-Richa
Journal:  Mol Divers       Date:  2018-03-13       Impact factor: 2.943

3.  A Theoretical and Experimental Study on the Potential Luminescent and Biological Activities of Diaminodicyanoquinodimethane Derivatives.

Authors:  Edison Rafael Jiménez; Manuel Caetano; Nelson Santiago; F Javier Torres; Thibault Terencio; Hortensia Rodríguez
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

4.  1-Ethyl-3-methyl-quinoxalin-2(1H)-one.

Authors:  Hanane Benzeid; Laure Vendier; Youssef Ramli; Bernard Garrigues; El Mokhtar Essassi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-31

5.  Ethyl 3-(3-oxo-3,4-dihydro-quinoxalin-2-yl)propano-ate.

Authors:  Waqar Nasir; Munawar Ali Munawar; Ahmad Adnan; Saeed Ahmad; Mohammad Akbar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-20

6.  1-Allyl-3-phenyl-quinoxalin-2(1H)-one.

Authors:  Hanane Benzeid; Rachid Bouhfid; Stephane Massip; Jean Michel Leger; El Mokhtar Essassi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-22

7.  Studies on the synthesis of derivatives of marine-derived bostrycin and their structure-activity relationship against tumor cells.

Authors:  Hong Chen; Lili Zhong; Yuhua Long; Jia Li; Jueheng Wu; Lan Liu; Shengping Chen; Yongcheng Lin; Mengfeng Li; Xun Zhu; Zhigang She
Journal:  Mar Drugs       Date:  2012-04-24       Impact factor: 6.085

8.  Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Authors:  Mohamed Alswah; Ashraf H Bayoumi; Kamal Elgamal; Ahmed Elmorsy; Saleh Ihmaid; Hany E A Ahmed
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

9.  A highly green approach towards aromatic nitro group substitutions: catalyst free reactions of nitroimidazoles with carbon nucleophiles in water.

Authors:  Syed Raza Shah; Muhammad Ali; Muhammad U Anwar; Ahmed Al-Harrasi
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 3.361

10.  Synthetic Derivatives against Wild-Type and Non-Wild-Type Sporothrix brasiliensis: In Vitro and In Silico Analyses.

Authors:  Lais Cavalcanti Dos Santos Velasco de Souza; Lucas Martins Alcântara; Pãmella Antunes de Macêdo-Sales; Nathália Faria Reis; Débora Sena de Oliveira; Ricardo Luiz Dantas Machado; Reinaldo Barros Geraldo; André Luis Souza Dos Santos; Vítor Francisco Ferreira; Daniel Tadeu Gomes Gonzaga; Fernando de Carvalho da Silva; Helena Carla Castro; Andréa Regina de Souza Baptista
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.